Skip to main content
Clinical Trials/NCT02654795
NCT02654795
Unknown
Not Applicable

AssesSment of the Left Atrial Appendage morphoLogy in Patients aAfter ischeMic Stroke

Centre of Postgraduate Medical Education1 site in 1 country200 target enrollmentAugust 2013
ConditionsIschemic Stroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ischemic Stroke
Sponsor
Centre of Postgraduate Medical Education
Enrollment
200
Locations
1
Primary Endpoint
The LAA morphology in patients with an elevated risk of peripheral thromboembolism defined as CHA2DS2-VAScore >2
Last Updated
10 years ago

Overview

Brief Summary

Stroke remains the most dangerous and frightening complication of atrial fibrillation (AF). Numerous factors predisposing to peripheral embolism in patients with AF have been well defined, documented and included in the CHA2DS2VASC score. Although proper anticoagulation minimizes the risk attributable to "known" risk factors, stroke may still occur. Thus, "unknown" risk factors may play an important role in stroke risk stratification in patients with AF. The investigators assume that one of the important "unknown" risk factor is left atrial appendage (LAA) morphology. The ASSAM study is planned to include 100 patients after ischemic stroke or transient ischemic attack (TIA) and known status of anticoagulation at the time of stroke. The control group will consist of 100 patients scheduled for AF ablation without a history of stroke or TIA.

Registry
clinicaltrials.gov
Start Date
August 2013
End Date
July 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Centre of Postgraduate Medical Education
Responsible Party
Principal Investigator
Principal Investigator

Jakub Baran MD PhD

Principal Investigator

Centre of Postgraduate Medical Education

Eligibility Criteria

Inclusion Criteria

  • history of ischemic stroke or transient ischemic attack
  • history of AF/AL
  • known status of anticoagulation at the time of stroke (treatment dose, INR level)

Exclusion Criteria

  • hemorrhagic stroke
  • serious renal impairment with GFR \<30 ml/min
  • hyperthyroidism
  • allergy to the contrast agent
  • mental inability to sign the informed consent
  • receptive aphasia

Outcomes

Primary Outcomes

The LAA morphology in patients with an elevated risk of peripheral thromboembolism defined as CHA2DS2-VAScore >2

Time Frame: Through study completion, an average of 1 year

The investigators will examine association of specific type of LAA morphology with ischemic stroke taking in to account anticoagulation in the time of stroke/TIA. The morphology of LAA will be divided into 4 types: * the chicken wing - LAA with only one lobe, its length exceeds 40 mm and its bend angle is less than 100 degrees * the windsock - LAA with one dominant lobe (length \> 40 mm) and several secondary, or even tertiary ones, its length exceeds 40 mm and its bend angle exceeds 100 degrees * the cauliflower - LAA with a variable number of lobes with lack of a dominant lobe, its total length is less than 40 mm * the cactus - LAA with a dominant central lobe with several secondary ones, its total length less than 40 mm

Study Sites (1)

Loading locations...

Similar Trials